Aquinox Pharma (AQXP) Posts Narrower-than-Expected Q3 Loss

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/14/2026

1. CSCO
2. CBRS
3. COHR
4. SPY
5. BTGO
6. NVDA
7. WYFI
8. STUB
9. EAT
10. BIRK

Go back to Aquinox Pharma (AQXP) Posts Narrower-than-Expected Q3 Loss

Leerink Maintains Aquinox Pharma (AQXP) at 'Outperform'; End-of-Phase 2 FDA Meeting is Next Catalyst

November 10, 2015 2:18 PM EST

Leerink affirms Aquinox Pharma (Nasdaq: AQXP) with an Outperform rating and $26 price target following the company's Q3 results and update... More